Cargando…
Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide
Triple-negative breast cancers (TNBCs) are aggressive cancers, which currently do not have effective treatment options. Migration and establishment of metastatic colonies require dynamic cytoskeletal modifications characterized by polymerization and depolymerization of actin. Studies have demonstrat...
Autores principales: | Arumugam, Arunkumar, Subramani, Ramadevi, Lakshmanaswamy, Rajkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972938/ https://www.ncbi.nlm.nih.gov/pubmed/33768141 http://dx.doi.org/10.1016/j.omto.2021.02.014 |
Ejemplares similares
-
Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition
por: Subramani, Ramadevi, et al.
Publicado: (2016) -
Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis
por: Mehmetoglu-Gurbuz, Tugba, et al.
Publicado: (2023) -
Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
por: Subramani, Ramadevi, et al.
Publicado: (2014) -
Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
por: Subramani, Ramadevi, et al.
Publicado: (2014) -
Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
por: Arumugam, Arunkumar, et al.
Publicado: (2019)